Related Experiment Video

Updated: Jul 25, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K

The applications and techniques of organoids in head and neck cancer therapy

Hao Qi1,2, Xiaolin Tan1,3, Wenshuo Zhang4

  • 1The Cancer Center, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.

Frontiers in Oncology
|July 10, 2023
PubMed

Insights

Patient-derived organoids (PDOs) offer a high-fidelity model for studying head and neck cancer (HNC) biology. These organoids show significant promise for advancing precision medicine and developing novel HNC therapies.

Area of Science:

  • Oncology
  • Biotechnology
  • Cancer Research

Background:

  • Head and neck cancer (HNC) presents a significant global health challenge, with high incidence and mortality rates.
  • Limited progress in understanding HNC's biological underpinnings has hindered the development of effective treatments.
  • Patient-derived organoids (PDOs) are emerging as powerful tools to model HNC.

Purpose of the Study:

  • To review advancements in organoid technology for head and neck cancer research.
  • To discuss the application of HNC organoids in precision medicine and therapeutic development.
  • To explore the potential and limitations of organoid models in HNC studies.

Main Methods:

  • Review of recent publications on head and neck cancer organoid techniques.
  • Analysis of studies utilizing patient-derived organoids for HNC modeling.
  • Discussion of organoid applications in cancer biology and drug discovery.

Main Results:

  • Organoid technologies have advanced significantly, offering high-fidelity models of HNC.
  • Organoids enable detailed study of HNC biology and facilitate the identification of targeted therapies.
  • Current research highlights the potential of organoids for personalized medicine approaches in HNC.

Conclusions:

  • Organoid models are crucial for advancing head and neck cancer research and understanding tumor heterogeneity.
  • The integration of organoids into precision medicine programs will significantly impact future HNC therapeutic strategies.
  • Further development and application of organoid technologies are essential for improving patient outcomes in HNC.
Keywords:
drug testinghead and neck cancerorganoidsprecision medicinetechniques

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.4K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

241

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.